Promotion earns the script. Experience realizes value.
I help pharma companies build the experiences that turn more scripts into patient and commercial impact.
Commercial Systems Architecture for Consumer-Grade Pharma™
Science that never reaches the patient helps no one.
In some therapeutic areas, up to half of written prescriptions never become therapy. Rebuilding your commercial system to the Consumer-Grade Pharma™ standard is how that gap closes.
The value is lost after the script, where it rarely shows up.
-
Promotion runs as a system. What follows the script does not.
Field, access, specialty pharmacy, patient services, reimbursement and medical each work from their own data and their own measure of success.
-
Consumer-Grade expectations raise the stakes.
Patients and HCPs compare every handoff with the best service they get anywhere. Companies that close the gap take share.
-
The loss is large and mostly invisible.
Business reviews track scripts written, so value lost after the script rarely appears in any report.
Together, we will build experience into your commercial system and win back the value lost after the script.
The value in Fig. 01 is not lost to weak promotion. It is lost in the handoffs after the script, where each function runs on its own data and its own measure of success. I bring a consumer-grade standard learned outside pharma and the experience of building it into the commercial system at Pfizer and Bayer. You bring the brand, the teams and the decisions that make it stick.
What makes the change structural, systemic and lasting
- 01 · Structural
Value after the script gets an accountable owner.
I redesign how the journey after the script is owned, measured and reviewed, so the value lost there appears in your business review with an accountable owner and a figure against it.
- 02 · Systemic
The handoffs run as one system.
Field, access, specialty pharmacy, patient services and medical connect around one measure of realized value, held to the consumer-grade standard I learned outside pharma and built into the commercial system at Pfizer and Bayer.
- 03 · Lasting
The change is built into the DNA.
Leadership decisions, incentives and ways of working are reset around the experience, so the gains hold long after the engagement ends.
Why it matters to you. Promotion already earns the script. Structural and systemic change is what lets more of that earned value reach patients, and lets you see it in your numbers.
How the work runs →How close is your organization to consumer-grade?
The distance between the science you deliver and the experience that surrounds it can be measured. In about fifteen minutes, the assessment scores your commercial organization against the six conditions of the Consumer-Grade Pharma™ standard and shows where the change has to be made.
Where the work happens: brand, field and culture.
Each one runs on the same operating system: a standard for what your customers should experience, a formula for how your value is realized and a ladder that puts a figure on each stage after the prescription.

For when you want more of your demand to turn into patients on therapy, with a clear view of where value slips after the prescription.
Runs as · Realization Management SystemFor when you want what your reps see to reach the teams who can act on it.
Runs as · FieldOSFor when you want the gains in brand and field to hold.
Runs as · Customer-Centric Operating ModelSee how the three fit together, and where most clients start.
Proven inside global pharma.
Results from my in-house commercial leadership roles at global pharma companies.
Brand launch recovery
A stalled priority launch returned to growth with no added promotion.
Field force rewired
Revenue uplift after frontline and HCP feedback changed how the field works.
Markets rewired
Markets rewired around customer signals across digital, field and consumer channels.
An outside perspective, forged in-house.
“For the first twenty years of my career, I worked in industries where you knew when you lost a customer. They left, and the business felt it almost immediately. Pharma challenged that thinking. Patients leave too, but it can take 90 days to show up, and rarely is that loss fully recognized. At Pfizer and Bayer, I saw firsthand how these invisible losses affect commercial performance. That experience shaped my work to position customer experience not simply as a measure of satisfaction, but as an integral part of the commercial system, driving performance, growth, and value creation.”
Wayne Simmons · Founder
I help pharma companies build the Consumer‑Grade experiences worthy of their breakthrough science.

